Anesthetic management of Prader–Willi syndrome: what if neuromuscular relaxants could not be avoided?

2011 ◽  
Vol 26 (2) ◽  
pp. 304-305 ◽  
Author(s):  
Amit Jain ◽  
Indu Bala ◽  
Jeetinder Kaur Makkar
2002 ◽  
Vol 22 (7) ◽  
pp. 300-302
Author(s):  
Shinichiro TAKAHASHI ◽  
Masaki NAKANE ◽  
Manabu HARADA ◽  
Masao SUZUKI ◽  
Manabu OTSUKI ◽  
...  

2004 ◽  
Vol 47 (3) ◽  
pp. 439
Author(s):  
Sam Hong Min ◽  
Choon Hak Lim ◽  
Hye Won Lee ◽  
Hae Ja Lim ◽  
Suk Min Yoon ◽  
...  

1976 ◽  
Vol 44 (2) ◽  
pp. 161-163 ◽  
Author(s):  
SUSAN K. PALMER ◽  
JOHN L. ATLEE

2020 ◽  
Vol 8 ◽  
pp. 2050313X2092761
Author(s):  
Kyung Woo Kim ◽  
Seung Hwan Kim ◽  
Eun Jin Ahn ◽  
Hyo Jin Kim ◽  
Hey Ran Choi ◽  
...  

Prader–Willi syndrome is a genetic disorder that is characterized by obesity, characteristic facial features, hypotonia, and sleep apnea. These abnormalities mean that airway management is difficult in such patients. Several previous reports suggest that neuromuscular blocking agents should not be used to reduce airway and respiratory complications in these patients. However, this is not always possible. Here, we report the case of a patient with Prader–Willi syndrome in whom anesthesia for ophthalmic surgery was managed successfully using sugammadex after administration of rocuronium.


2014 ◽  
Vol 31 ◽  
pp. 275
Author(s):  
A. Martín ◽  
M. Granell ◽  
M.Á. Pallardó ◽  
F. Tornero ◽  
E. Zapater ◽  
...  

2009 ◽  
Vol 57 (2) ◽  
pp. 259 ◽  
Author(s):  
Jae Young Kim ◽  
Ji Hyang Lee ◽  
Eun Joo Kim ◽  
Sang Kon Lee ◽  
Jong Suk Ban ◽  
...  

1996 ◽  
Vol 71 (4) ◽  
pp. 187-212 ◽  
Author(s):  
Travis Thompson ◽  
Merlin Butler ◽  
William MacLean ◽  
Beth Joseph

Sign in / Sign up

Export Citation Format

Share Document